{"nct_id":"NCT04108195","title":"A Study of Subcutaneous Daratumumab Regimens in Combination With Bispecific T Cell Redirection Antibodies for the Treatment of Participants With Multiple Myeloma","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-07","start_date":"2020-02-21","start_date_type":"ACTUAL","primary_completion_date":"2025-08-22","primary_completion_date_type":"ESTIMATED","completion_date":"2027-04-07","completion_date_type":"ESTIMATED","phases":["PHASE1"],"tickers":["JNJ"]}